Your browser doesn't support javascript.
loading
[Efficacy and safety analysis of a combination regimen with BCL-2 inhibitor in relapsed/refractory primary systemic light chain amyloidosis with t(11;14) from a single center].
Zhai, A L; Liu, Y; Peng, N; Gong, L Z; Dou, X L; Wen, L; Lu, J.
Afiliação
  • Zhai AL; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Liu Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Peng N; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Gong LZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Dou XL; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Wen L; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Lu J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Zhonghua Nei Ke Za Zhi ; 62(11): 1323-1328, 2023 Nov 01.
Article em Zh | MEDLINE | ID: mdl-37935499
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose / Antineoplásicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose / Antineoplásicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article